Authors

• Raija Ristamäki (ORCID: https://orcid.org/0000-0001-6817-3045)
• Päivi Halonen (ORCID: https://orcid.org/0000-0002-9760-0840)
• Eetu Heervä (ORCID: https://orcid.org/0000-0002-6134-1170)
• Annika Ålgars (ORCID: https://orcid.org/0000-0002-9841-1881)
• Annamarja Lamminmäki (ORCID: https://orcid.org/0000-0001-7664-4468)
• Aki Uutela (ORCID: https://orcid.org/0000-0003-1324-5894)
• Maarit Tuulikki Barlund (ORCID: https://orcid.org/0000-0002-1469-5654)
• Hanna Stedt
• Emerik Österlund (ORCID: https://orcid.org/0000-0003-0973-6332)
• Kaisa Lehtomäki (ORCID: https://orcid.org/0000-0002-2994-1459)
• Pia J. Osterlund (ORCID: https://orcid.org/0000-0002-7124-3515)
• Timo Muhonen
• Tuija Poussa (ORCID: https://orcid.org/0000-0003-1452-0974)
• Joel Kontiainen
• Sonja Aho (ORCID: https://orcid.org/0000-0002-4965-5580)
• Tapio K. Salminen (ORCID: https://orcid.org/0000-0002-5899-0233)
• Jarmo Hahl
• Iiro Toppila
• Bengt Glimelius
• Helena Isoniemi
• Arno Nordin
• Raija Kallio

Institutions

• Uppsala University (SE)
• Statistics Finland (FI)
• University of Helsinki (FI)
• Uppsala University Hospital (SE)
• University of Turku (FI)
• University of Eastern Finland (FI)
• Nokia (Finland) (FI)
• Oulu University Hospital (FI)
• Helsinki University Hospital (FI)
• Turku University Hospital (FI)
• Kuopio University Hospital (FI)
• Tampere University Hospital (FI)
• Tampere University (FI)
• University of Oulu (FI)

Publication Details

Journal

Acta Oncologica

Published

2026-02-03

DOI

https://doi.org/10.2340/1651-226x.2026.45005

Primary Topic

Economic and Financial Impacts of Cancer

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Amgen
• Eli Lilly and Company
• Sanofi
• Suomen Lääketieteen Säätiö
• Merck KGaA
• Finska Läkaresällskapet
• Mary och Georg C. Ehrnrooths Stiftelse
• Cancerfonden
• Fondation pour la Recherche Médicale
• Tays
• Servier